LBODP028 Identifying Biomarkers For Predicting Response To Mineralocorticoid Receptor Antagonist Treatment In Heart Failure

Despite significant improvements to patient care, heart failure (HF) remains a major public health burden. Mineralocorticoid receptor antagonists (MRAs) reduce hospitalisation and improve survival in patients with HF with reduced ejection fraction (HFrEF) but the widespread use of MRAs is limited by...

Descripción completa

Detalles Bibliográficos
Autores principales: Karthigan, Nikshay, Lockwood, Siobhan, White, Anthony, Yang, Jun, Young, Morag Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624640/
http://dx.doi.org/10.1210/jendso/bvac150.483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624640/
http://dx.doi.org/10.1210/jendso/bvac150.483

Ejemplares similares